Publisher: PRO.MED.CS Praha a.s., Telčská 377/1, Michle, 140 00 Praha 4, Czech Republic
PROGIT 50 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White to almost white round biconvex scored film-coated tablets, diameter 7 mm. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each film-coated tablet contains 50 mg of itopride hydrochloride.
Excipients with known effect: Each film-coated tablet contains 74.68 mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Itopride |
Itopride activates the gastrointestinal propulsive motility by dopamine D2 receptors antagonistic action and acetylcholine esterase inhibitory action. Itopride activates acetylcholine release and inhibits its degradation. |
| List of Excipients |
|---|
|
Lactose monohydrate Coating composition Opadry II White 85F18422: Partially hydrolyzed polyvinylalcohol |
OPA/Al/PVC/Al blister or transparent PVC/PVdC/Al blister, carton.
Pack size: 10, 20, 30, 40, 90 or 100 film-coated tablets.
Not all pack sizes may be marketed.
PRO.MED.CS Praha a.s., Telčská 377/1, Michle, 140 00 Praha 4, Czech Republic
| Drug | Countries | |
|---|---|---|
| PROGIT | Lithuania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
